Mutations in the C-terminus of CDKL5: proceed with caution

Area of Science:

• Genetics
• Molecular Biology
• Neurology

Background:

• Mutations in the cyclin-dependent kinase-like 5 (CDKL5) gene are linked to Rett-like features and early-onset epileptic encephalopathy.
• Milder phenotypes have been associated with variations in the 3'-end of the CDKL5 gene.
• Novel CDKL5 transcripts suggest altered C-terminal regions, questioning the pathogenicity of 3'-end variations.

Purpose of the Study:

• To investigate the clinical significance of CDKL5 gene variations, particularly in the 3'-end.
• To evaluate the pathogenicity of identified CDKL5 mutations in patients with heterogeneous neurological phenotypes.

Main Methods:

• Genetic analysis of 30 female patients with phenotypes ranging from intellectual disability to neonatal encephalopathy.
• Identification and characterization of CDKL5 missense mutations.
• Comparison of patient mutations with those found in healthy family members and literature data.

Main Results:

• Two heterozygous CDKL5 missense mutations, p.Val999Met and p.Pro944Thr, were identified in patients.
• These mutations were also found in the healthy father of the affected patients.
• Genetic variations beyond codon 938 in the CDKL5 protein may have limited clinical significance.

Conclusions:

• Sequence variations in the 3'-end of the CDKL5 gene (beyond codon 938) may not be clinically significant for conditions like atypical Rett syndrome.
• Screening exons 19-21 of the CDKL5 gene might not be beneficial for molecular diagnosis.
• Further research is needed to fully understand the role of CDKL5 in neurological disorders.